米国の腫瘍情報システム市場規模、シェア、動向分析レポート：製品・サービス別、用途別、最終用途別、セグメント予測、2025年～2030年

市場規模と動向

米国の腫瘍情報システム（OIS）市場規模は2024年に9億29万米ドルと推定され、2025～2030年にかけてCAGR 7.40％で成長すると予測されています。

さまざまな層でがんの有病率が高まっていることや、先進的な革新的腫瘍情報システム（OIS）に対する需要が高まっていることが、米国の腫瘍情報システム産業の促進要因となっています。米国の病院やがん研究機関では、がん有病率の上昇と医療費予算の増加により、がん情報ソリューションの導入が進んでいます。

米国のOIS産業は、がん罹患率の上昇と先進的ヘルスケアITソリューションの統合の増加により、大きく成長する見込みです。米国国立がんラボによると、2024年には米国で新たに200万人以上のがん患者が発生し、がん関連死は61万1,720人に上ると予測されています。このような疾病罹患率の増加により、堅牢なデータ管理と臨床意思決定支援システムが必要となり、ヘルスケア施設全体でOISプラットフォームへの需要が加速しています。

さらに、米国のヘルスケア部門では、ワークフロー、管理機能、患者ケア提供の最適化を目的としたデジタル技術の導入が急増しています。治療計画、データ可視化、患者追跡などの先進的機能を備えた腫瘍学情報システムは、臨床転帰と業務効率を改善するための重要なツールとして台頭しています。

さらに、公的機関や民間団体の支援による腫瘍学研究開発への投資拡大が、製品の技術革新を促進しています。例えば、1978年に設立された著名な非営利団体American Brachytherapy Society（ABS）は、専門家教育、研究促進、認知度向上のイニシアチブを通じて、積極的にブラキセラピーの進歩を支援しています。このような組織は、がん医療における技術革新と知識の普及を推進する上で極めて重要な役割を果たしています。

さらに、人工知能（AI）の腫瘍学ワークフローへの統合が進んでいることも、市場拡大をさらに促進すると予想されます。2024年10月、McKesson Corporationの子会社であるOntadaは、Azure OpenAI Serviceを含むAzure AIを活用して非構造化腫瘍学データの処理を強化するためにMicrosoftと提携しました。この提携は、複雑な臨床文書から実用的な洞察を引き出し、最終的にデータ主導の治療計画とリアルタイムの意思決定を支援することを目的としています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の腫瘍情報システム市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助的な市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 米国の腫瘍情報システム市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国の腫瘍情報システム市場：製品・サービス別、推定・動向分析

• セグメントダッシュボード
• 米国の腫瘍情報システム市場の製品・サービスの変動分析
• 米国の腫瘍情報システム市場規模と動向分析（製品・サービス別、2018～2030年）
• ソフトウェア
  • 患者情報システム
  • 治療計画システム
• プロフェッショナルサービス

第5章 米国の腫瘍情報システム市場：用途別、推定・動向分析

• セグメントダッシュボード
• 米国の腫瘍情報システム市場用途変動分析
• 米国の腫瘍情報システム市場規模と動向分析（用途別、2018～2030年）
• 腫瘍内科
• 放射線腫瘍学
• 外科腫瘍学

第6章 米国の腫瘍情報システム市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 米国の腫瘍情報システム市場の最終用途変動分析
• 米国の腫瘍情報システム市場規模と動向分析（最終用途別、2018～2030年）
• 病院と診断画像
• アブレーションケアセンターとがんケアセンター
• 政府機関
• 調査施設

第7章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2024年
• 企業プロファイル/上場企業
  • Elekta AB
  • Accuray Incorporated
  • Varian Medical Systems（Siemens Healthineers）
  • RaySearch Laboratories
  • Cerner Corporation（Oracle Corporation）
  • BrainLab
  • Philips Healthcare
  • Prowess, Inc.
  • DOSIsoft SA
  • ViewRay Inc.
  • MIM Software
  • Flatiron

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. oncology information systems market, by component, 2018 - 2030 (USD Million)
• Table 3 U.S. oncology information systems market, by application, 2018 - 2030 (USD Million)
• Table 4 U.S. oncology information systems market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 U.S. oncology information systems market: Market outlook
• Fig. 5 U.S. oncology information systems market: Segment outlook
• Fig. 6 U.S. oncology information systems market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 U.S. oncology information systems market driver impact
• Fig. 9 U.S. oncology information systems market restraint impact
• Fig. 10 U.S. oncology information systems market: Products & Services outlook and key takeaways
• Fig. 11 U.S. oncology information systems market: Products & Services movement analysis
• Fig. 12 Software market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 13 Patient information systems market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Treatment planning systems market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Professional services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 16 U.S. oncology information systems market: Application outlook and key takeaways
• Fig. 17 U.S. oncology information systems market: Application movement analysis
• Fig. 18 Medical oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Medical oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Surgical oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 U.S. oncology information systems market: end use outlook and key takeaways
• Fig. 22 U.S. oncology information systems market: end use movement analysis
• Fig. 23 Hospitals & diagnostic imaging centers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Ablation care centers and cancer care centers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Government institutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Research facilities market estimates and forecasts, 2018 - 2030 (USD Million)

Market Size & Trends:

The U.S. oncology information systems market size was estimated at USD 900.29 million in 2024 and is projected to grow at a CAGR of 7.40% from 2025 to 2030. The growing prevalence of cancer among various demographics and the rising demand for advanced innovative oncology information systems (OIS) are some of the driving factors for the U.S. oncology information systems industry. Oncology information solutions deployment is high in hospitals & cancer research institutes in the U.S. due to the rise in the prevalence of cancer and the increase in healthcare expenditure budget.

The U.S. OIS industry is poised for significant growth, driven by the rising cancer burden and the increasing integration of advanced healthcare IT solutions. According to the National Cancer Institute, over 2 million new cancer cases are projected to be diagnosed in the U.S. in 2024, with an estimated 611,720 cancer-related deaths. This escalating disease incidence necessitates robust data management and clinical decision support systems, thereby accelerating the demand for OIS platforms across healthcare facilities.

Moreover, the healthcare sector in the U.S. has witnessed a surge in the adoption of digital technologies aimed at optimizing workflows, administrative functions, and patient care delivery. Oncology information systems, equipped with advanced functionalities such as treatment planning, data visualization, and patient tracking, have emerged as critical tools for improving clinical outcomes and operational efficiency.

Furthermore, increased investment in oncology R&D, supported by both public and private organizations, is fostering product innovation. For instance, the American Brachytherapy Society (ABS), a prominent nonprofit founded in 1978, actively supports the advancement of brachytherapy through professional education, research promotion, and awareness-building initiatives. Such organizations play a pivotal role in driving innovation and knowledge dissemination in oncology care.

In addition, the growing integration of artificial intelligence (AI) into oncology workflows is expected to further propel market expansion. In October 2024, Ontada, a McKesson Corporation subsidiary, partnered with Microsoft to utilize Azure AI, including Azure OpenAI Service, to enhance the processing of unstructured oncology data. This collaboration aims to extract actionable insights from complex clinical documents, ultimately supporting data-driven treatment planning and real-time decision-making.

U.S. Oncology Information Systems Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. oncology information systems market report based on products & services, application, and end use:

• Products & Services Outlook (Revenue, USD Million, 2018 - 2030)
• Software
  • Patient Information Systems
  • Treatment Planning Systems
• Professional Services
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Medical Oncology
• Radiation Oncology
• Surgical Oncology
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals & Diagnostic Imaging Centers
• Ablation Care Centers and Cancer Care Centers
• Government Institutions
• Research Facilities

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Products & Services Segment
  • 1.2.2. Application Segment
  • 1.2.3. End Use
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. U.S. Oncology Information Systems Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenges analysis
• 3.3. U.S. Oncology Information Systems Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal Landscape
    • 3.3.2.6. Social Landscape

Chapter 4. U.S. Oncology Information Systems Market: Products & Services Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Oncology Information Systems Market Products & Services Movement Analysis
• 4.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by Products & Services, 2018 to 2030 (USD Million)
• 4.4. Software
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Patient Information Systems
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Treatment Planning Systems
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Professional Services
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Oncology Information Systems Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Oncology Information Systems Market Application Movement Analysis
• 5.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Medical Oncology
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Radiation Oncology
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Surgical Oncology
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Oncology Information Systems Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Oncology Information Systems Market End Use Movement Analysis
• 6.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals & Diagnostic Imaging
  • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Ablation Care Centers and Cancer Care Centers
  • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Government Institutions
  • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Research Facilities
  • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2024
• 7.4. Company Profiles/Listing
  • 7.4.1. Elekta AB
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Accuray Incorporated
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Varian Medical Systems (Siemens Healthineers)
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. RaySearch Laboratories
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Cerner Corporation (Oracle Corporation)
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. BrainLab
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Philips Healthcare
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Prowess, Inc.
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. DOSIsoft S.A.
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. ViewRay Inc.
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. MIM Software
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. Flatiron
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives